Qing Hao

Artemisia annua

Also known as: Sweet Annie(English) Sweet Wormwood(English) Annual Wormwood(English) Qing Hao(Chinese (Pinyin)) 青蒿(Chinese)

Ch'ing Hao

Updated October 23, 2026 · Not yet clinically reviewed

Qing Hao

Safety at a glance

Note

2 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cold
Taste
Bitter,Pungent
Channels
Kidney,Liver,Gallbladder,Bladder,Stomach,Triple Burner (San Jiao)

Functions

Clears Summerheat or Damp-Heat; Clears Deficiency fevers; Cools the Blood and stops bleeding; Stops malarial disorders and relieves Heat; Clears Liver Heat and brightens the eyes

Traditional uses

Qing Hao (sweet wormwood, artemisia) is a bitter, cold, aromatic herb with its most famous application as the source of artemisinin — the compound that has revolutionized modern malaria treatment. In traditional Chinese medicine, it is used to clear deficiency Heat from the Ying-Blood level — addressing the night fever and morning coolness pattern of late-stage febrile disease — and to treat malaria with alternating chills and fever. It also clears summerheat and relieves jaundice from Damp-Heat.

Western herbalism

Properties: antimicrobial, anti-inflammatory, antipyretic, antioxidant

Pharmacological effects

  • Antimalarial: Artemisinin (identified 1972) is highly active against Plasmodium incl. multidrug-resistant P. falciparum and early gametocytes, without marked cross-resistance with chloroquine; heme-catalysed peroxide reduction generates toxic radicals; methoxylated flavonoids and arteannuin B potentiate it.
  • Antiprotozoal: Artemisinin was effective against schistosomiasis in mice, rabbits and monkeys, inhibited Toxoplasma gondii and was active against Leishmania major in mice.
  • Antipyretic and antiinflammatory: Water, ethyl acetate and n-butanol extracts were antipyretic, antiinflammatory, analgesic and bacteriostatic in animals; qinghao acid antibacterial, scopoletin antiinflammatory.
  • Cytotoxic: Artemisinin and related endoperoxides cytotoxic to Ehrlich ascites cells; artemisinin and quercetagetin 6,7,3',4'-tetramethyl ether cytotoxic to several tumor cell lines.
  • Other effects: Extracts immunomodulatory (not via artemisinin); artemisinin reduced heart rate, contractility and coronary flow in isolated rabbit heart and was antiarrhythmic against aconitine in rabbits at 12 mg/kg i.v.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 221.

Formulas using this herb

7 of 7 formulas

Botanical

Artemisia annua is an aromatic annual herb in the daisy family (Asteraceae), growing 30-100 cm tall. Stems are erect, much-branched, and longitudinally grooved. Leaves are alternate, deeply 2-3 times pinnately dissected into narrow lobes, strongly aromatic with a sweet camphor-like scent. Tiny, globose, yellow flower heads are numerous and borne in loose, branched panicles. The whole plant is glandular-pubescent with a distinctive sweet-camphor fragrance. This species is the source of the antimalarial drug artemisinin.

Family
Asteraceae
Pharmaceutical name
Herba Artemisiae Annuae
Parts used
whole_plant, leaf, stem
Plant type
herb
Native region
Afghanistan, Algeria, Altay, Amur, Borneo, Bulgaria, Buryatiya, Central European Rus, China North-Central, China South-Central, China Southeast, Chita, Cyprus, East European Russia, East Himalaya, Egypt, Greece, Hainan, India, Inner Mongolia, Iran, Iraq, Irkutsk, Japan, Jawa, Kazakhstan, Khabarovsk, Kirgizstan, Korea, Krasnoyarsk, Krym, Lebanon-Syria, Lesser Sunda Is., Libya, Malaya, Maluku, Manchuria, Mongolia, Morocco, Myanmar, Nepal, North Caucasus, Northwest European R, Pakistan, Philippines, Primorye, Qinghai, Romania, South European Russi, Sulawesi, Sumatera, Tadzhikistan, Taiwan, Tibet, Transcaucasus, Tunisia, Turkey, Turkey-in-Europe, Turkmenistan, Tuva, Uzbekistan, Vietnam, West Himalaya, Western Sahara, Xinjiang
Conservation status
least_concern

Habitat

Disturbed habitats, roadsides, rocky slopes, and waste places; native to temperate Asia (China, Russia), now widely naturalized and cultivated throughout tropical and temperate regions worldwide.

Conservation notes

Artemisia annua is a common and widespread plant, widely cultivated for artemisinin production. High demand has led to large-scale commercial cultivation. No conservation concerns.

Constituents

Artemisinin (qinghaosu)

Sesquiterpene lactone (endoperoxide) · ~0.01-1.5% of dry leaf

The signature endoperoxide-bridge sesquiterpene lactone of the plant. Activated by heme/ferrous iron within Plasmodium, it generates carbon-centered free radicals and reactive oxygen species that alkylate parasite proteins, producing rapid schizonticidal activity. Its semisynthetic derivatives (artesunate, artemether, dihydroartemisinin) are the backbone of WHO-recommended artemisinin-based combination therapy.

Artemisinic acid (arteannuic acid)

Amorphane sesquiterpenoid · Often exceeds artemisinin in leaf

A biosynthetic precursor to artemisinin and a target for semisynthetic and fermentation-based artemisinin production. It contributes to the antiplasmodial activity of whole-plant preparations and shows anti-inflammatory activity in vitro.

Dihydroartemisinic acid

Sesquiterpenoid · Variable, chemotype-dependent

The immediate precursor that is oxidised (partly non-enzymatically, driven by singlet oxygen and light) to artemisinin. Its abundance largely determines a chemotype's artemisinin yield.

Arteannuin B

Sesquiterpene lactone · Minor

A co-occurring sesquiterpene lactone reported to act synergistically with artemisinin against Plasmodium in whole-plant extracts, contributing to the enhanced parasite clearance seen with plant matrix preparations versus pure artemisinin.

Scopoletin

Coumarin · Minor

A hydroxycoumarin with anti-inflammatory and antioxidant activity that is proposed to enhance the pharmacokinetics/bioavailability of artemisinin in tea and extract preparations.

Casticin / chrysosplenol D / artemetin

Polymethoxylated flavonoids · Trace to minor

Methoxylated flavones that potentiate the antimalarial action of artemisinin in vitro and contribute anti-inflammatory and antioxidant effects to the whole herb.

Essential oil (artemisia ketone, camphor, 1,8-cineole, caryophyllene)

Volatile terpenoids · ~0.2-0.5% (v/w)

The aromatic fraction responsible for the herb's characteristic smell; shows antimicrobial and antipyretic activity and, being heat-labile, informs the traditional caution against prolonged boiling.

Drug interactions

CYP2C19 substrates (e.g., omeprazole, clopidogrel)

Moderate · May increase plasma levels of the co-administered substrate · Evidence level: Probable

Artemisinin and its derivatives reversibly inhibit CYP2C19 (and CYP1A2) in human liver microsomes and in healthy volunteers, which can slow the clearance of drugs metabolised by these enzymes.

Clinical note: Monitor for exaggerated effect of narrow-therapeutic-index CYP2C19 substrates during concurrent use of concentrated Artemisia annua or artemisinin products.

CYP3A4 substrates (e.g., midazolam, some statins, oral contraceptives)

Moderate · May reduce efficacy of the co-administered substrate over repeated dosing · Evidence level: Probable

Artemisinin activates the xenosensors PXR and CAR and induces CYP3A4, CYP2B6 and MDR1, and displays autoinduction of its own metabolism on repeated dosing, potentially lowering exposure to CYP3A4 substrates.

Clinical note: Consider reduced effect of CYP3A4-dependent medicines (including hormonal contraceptives) with prolonged high-dose use; time-separation and monitoring advised.

Dosage

FormAmountFrequencyPopulationNotes
decoction6–12 gdailyadult
中国药典 2020年版 一部 【青蒿】【用法与用量】6~12g,后下。 — Chinese Pharmacopoeia 2020, Vol. I. Add near end of decoction; do not cook long as active constituents are heat-labile

Preparations

Late-added decoction (hou xia)

Parts used: aerial parts, leaf

Typical adult dose 6-12 g. Because the active endoperoxide and volatile constituents are heat-labile, Qing Hao is added near the end of cooking and only briefly simmered, or steeped, rather than boiled at length with other herbs.

Fresh juice / cold-water maceration

Parts used: fresh aerial parts

Following Ge Hong's classical method for intermittent fevers, fresh herb is soaked in water and wrung out to express the juice, taken cold. This cold-extraction approach, which preserves artemisinin, famously guided Tu Youyou's isolation of the compound.

Powder or granule/tablet

Parts used: dried aerial parts

Dried herb is milled to powder or made into standardized extracts/tablets for consistent dosing in modern clinical use; concentrated extracts are used in the rheumatology trials described above.

Dui yao: classical pairings

Qing Hao + Bie Jia鳖甲

Together they enter the yin level to clear deep-lying heat and vent it outward, while nourishing yin, addressing heat that lingers after a febrile illness.

Classic indication: night fevers with morning coolness and no sweating in the late stage of warm disease.

Core pair of a classical formula — Qing Hao Bie Jia Tang, Wen Bing Tiao Bian (Wu Jutong, 1798)

Qing Hao + Huang Qin黄芩

Together they clear and vent damp-heat from the Gallbladder and shaoyang, resolving alternating chills and fever with bitter taste and nausea.

Core pair of a classical formula — Hao Qin Qing Dan Tang, Chong Ding Tong Su Shang Han Lun (Yu Genchu; revised He Lianchen)

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
3

Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial

Yang M, Guo MY, Luo Y, Yun MD, Yan J, Liu T, Xiao CH · Chinese Journal of Integrative Medicine · 2017 · Randomized controlled trial

Randomized controlled trial · Verified

159 patients with active rheumatoid arthritis received leflunomide plus methotrexate with or without Artemisia annua extract (30 g/day) for 48 weeks. The extract group showed significantly greater improvement in pain, tender-joint count and ESR from as early as 12 weeks, with greater overall efficacy at 24 and 48 weeks and no increase in adverse events.

doi:10.1007/s11655-016-2650-7

A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the hip and knee

Stebbings S, Beattie E, McNamara D, Hunt S · Clinical Rheumatology · 2016 · Randomized placebo-controlled trial

Randomized controlled trial · Verified

42 patients with hip or knee osteoarthritis were randomised to low-dose (150 mg twice daily) or high-dose (300 mg twice daily) Artemisia annua extract or placebo for 12 weeks. The low-dose group showed a significant improvement in WOMAC total score versus placebo, with the extract generally well tolerated.

doi:10.1007/s10067-015-3110-z

Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects

Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV, Petzold MG, Simonsson USH, Ashton M · Fundamental & Clinical Pharmacology · 2007 · Clinical pharmacokinetic study

Randomized controlled trial · Verified

In healthy volunteers, artemisinin drugs modestly modulated cytochrome P450 activity: artemisinin inhibited CYP1A2 and CYP2C19 while inducing CYP3A4, supporting a genuine potential for herb-drug interactions with agents cleared by these pathways.

doi:10.1111/j.1472-8206.2007.00471.x

Safety

Contraindications

Its use is prohibited in patients with diarrhea due to weakness of the spleen and stomach.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 87–88.

Side effects

  • Non-toxic at therapeutic doses; few side effects compared with other antimalarials
  • Reported: nausea, vomiting, diarrhoea, dizziness, sinus bradycardia, acute psychoses in some patients

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 221.

Cultural and historical

Wushi'er Bing Fang (Prescriptions for Fifty-Two Ailments) · Western Han (unearthed at Mawangdui, c. 168 BCE)

One of the earliest records of qing hao being used medicinally, predating its formal materia medica entries.

Zhou Hou Bei Ji Fang (Handbook of Prescriptions for Emergencies), Ge Hong · Eastern Jin (c. 340 CE)

Records soaking a handful of qing hao in water, wringing out the juice and drinking it for intermittent (malarial) fevers - the cold-extraction hint that led Tu Youyou to isolate artemisinin.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming (1596)

Details qing hao's use for clearing heat, deficiency fevers and treating malarial and summer-heat disorders.

References

  1. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Medicine. 2011 doi:10.1038/nm.2471
  2. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985 doi:10.1126/science.3887571
  3. Yang M, Guo MY, Luo Y, et al.. Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial. Chinese Journal of Integrative Medicine. 2017 doi:10.1007/s11655-016-2650-7
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice